Orange Book product · Brand (NDA)

ARBLI

LOSARTAN POTASSIUM

Brand (NDA)NDA 218772RX SCIENTURE

Mar 13, 2025

Approved

Brand (NDA)

Application

Not listed

TE code

Listed patents

Approval
FDA approval date of this drug product.
Mar 13, 2025
1 yr 3 mo ago
Today
Patent 11890273 expires
Listed drug product patent expiration.
Oct 07, 2041
in 15 yr 6 mo
Patent 12156869 expires
Listed drug product patent expiration.
Oct 07, 2041
in 15 yr 6 mo
Patent 12156869 expires
Listed drug product patent expiration.
Oct 07, 2041
in 15 yr 6 mo
Patent 12156869 expires
Listed drug product patent expiration.
Oct 07, 2041
in 15 yr 6 mo
Patent 12605365 expires
Listed drug product patent expiration.
Oct 07, 2041
in 15 yr 6 mo
Patent 12605365 expires
Listed drug product patent expiration.
Oct 07, 2041
in 15 yr 6 mo

Active ingredient

LOSARTAN POTASSIUM

Strength

10MG/ML

Dosage form

SUSPENSION

Route

ORAL

TE code

Not listed

Application

NDA 218772

Product number

001

Marketing status

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
Patent	Expires	In	Type
11890273	Oct 07, 2041	in 15 yr 6 mo	Product
12156869	Oct 07, 2041	in 15 yr 6 mo	ProductU-4158
12156869	Oct 07, 2041	in 15 yr 6 mo	ProductU-4159
12156869	Oct 07, 2041	in 15 yr 6 mo	ProductU-4160
12605365	Oct 07, 2041	in 15 yr 6 mo	ProductU-4159
12605365	Oct 07, 2041	in 15 yr 6 mo	ProductU-4160